Session Tracks

This track will explore the underlying mechanisms that contribute to neurotoxic effects in neuronal cells. Emphasis will be placed on cellular pathways, molecular interactions, and genetic factors involved in neurotoxicity.

This session will focus on the neurotoxic effects of various pharmaceutical agents and their implications for patient safety. Researchers are invited to present findings on the mechanisms and outcomes of drug-induced neuronal injury.

This track aims to discuss innovative approaches to neuroprotection against toxic agents. Topics may include pharmacological interventions, lifestyle modifications, and novel therapeutic strategies.

This session will examine the impact of neurotoxic agents during critical periods of development. Research on the long-term consequences of early-life exposure to neurotoxins will be highlighted.

This track will delve into the intersection of neurobiology and toxicology, focusing on how toxic substances affect neural function and structure. Presentations will cover both experimental and clinical perspectives.

This session will address the effects of environmental toxins on neurological health. Studies on pollutants, heavy metals, and other environmental factors contributing to neurotoxicity will be discussed.

This track will highlight recent advancements in neurotoxicology research, including novel methodologies and technologies. Challenges in the field, such as regulatory issues and risk assessment, will also be addressed.

This session will focus on the clinical manifestations and management of neurotoxic effects in patients. Case studies and clinical trials that illustrate the impact of neurotoxicity on neurological disorders will be presented.

This track will explore the role of neurotoxicity in the pathogenesis of neurodegenerative diseases such as Alzheimer's and Parkinson's. Research on the interplay between toxic agents and disease progression will be emphasized.

This session will cover various research methodologies employed in the study of neurotoxicity. Emphasis will be placed on in vitro, in vivo, and computational approaches to understanding neurotoxic effects.

This track will discuss the regulatory frameworks governing neurotoxicity testing and assessment. Presentations will focus on guidelines, standards, and best practices for evaluating neurotoxic risks.